Device
Single vision lenses
Single vision lenses is a medical device with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
2
50%
Ph phase_3
2
50%
Phase Distribution
0
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution4 total trials
Phase 3Large-scale testing
2(50.0%)
N/ANon-phased studies
2(50.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(2)
Terminated(1)
Detailed Status
Completed2
Withdrawn1
Active, not recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 32 (50.0%)
N/A2 (50.0%)
Trials by Status
withdrawn125%
completed250%
active_not_recruiting125%
Recent Activity
1 active trials
Showing 4 of 4
active_not_recruitingnot_applicable
Clinical Evaluation of a Myopia Control Lens in Slowing Myopia Progression
NCT05331378
withdrawnphase_3
Bifocal Spectacles vs. Single Vision Spectacles for Esotropia Greater at Near
NCT05527015
completednot_applicable
Trial of Hoya SYNC III Design Lenses
NCT03831919
completedphase_3
Correction of Myopia Evaluation Trial (COMET)
NCT00000113
Clinical Trials (4)
Showing 4 of 4 trials
NCT05331378Not Applicable
Clinical Evaluation of a Myopia Control Lens in Slowing Myopia Progression
NCT05527015Phase 3
Bifocal Spectacles vs. Single Vision Spectacles for Esotropia Greater at Near
NCT03831919Not Applicable
Trial of Hoya SYNC III Design Lenses
NCT00000113Phase 3
Correction of Myopia Evaluation Trial (COMET)
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4